InvestorsHub Logo
icon url

rayovacAAA

10/08/18 2:11 PM

#168013 RE: Jonjones325 #168010

If we fail our first trial, we will be screwed and get thrown into penny land.



Missling needs to give the farm away to BP so we don't fail! Missling, sell the company for pennies on the dollar before we fail!
icon url

BIOChecker4

10/08/18 2:20 PM

#168016 RE: Jonjones325 #168010

Given the early and ambiguous clinical data on A2-73, no big pharma is going to offer Anavex terms that would be acceptable to the board, to management or to stockholders. Anavex is not a secret to the players in AD and other CNS diseases. TGD had had a presence at virtually every conference of any significance for years. If there were real interest on acceptable terms, a collaboration would have happened by now. IMO, Anavex will have to continue without a partner unless and until there is a very compelling data set from larger, well designed, placebo-controlled P3 trials.
icon url

Investor2014

10/08/18 2:22 PM

#168017 RE: Jonjones325 #168010

You mean partner like Neuren did on the cheap still with no Rett P3 trial in sight.